Colorectal Cancer — A Study of QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver
Citation(s)
A Phase II Study of Perioperative QBECO Site Specific Immunomodulator (Qu Biologics®) in Patients With Metastatic Colorectal Adenocarcinoma Within the Liver Undergoing Resection